Many considerations should not be overlooked.
Access to the IVD market in China is lengthy and complicated.
Although an expensive and challenging regulatory market, Japan’s aging population offers plenty of opportunities for device companies.
It’s critical to understand the characteristics of this country’s market to determine the most effective steps.
‘Value’ is the common thread in PwC’s annual report on top health industry trends.
As the Internet of Things and the reimbursement environment transform the healthcare ecosystem, device manufacturers must position themselves to adapt.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.
Correct usage of codes impacts product positioning, pricing, launch and customer support.
Should your IDE device be reimbursed? FDA’s latest draft guidance will help CMS make the decision.
Consider taking a multi-pronged approach to this complex landscape.